Antibodies: Basics, applications & advanced concepts

This learning journey offers an overview of antibodies, covering their structure, classes, and subclasses, and their role in the immune system. It explores the therapeutic applications of antibodies, including their use in cancer, Type-1 diabetes, and transplant tolerance, while also addressing advanced concepts like antibody engineering, humanization, and the role of autoantibodies in autoimmune diseases.


1. An Introduction to Antibodies and their Structure

By Dr. Mike Clark – University of Cambridge, UK

An excerpt from Antibody structure and function: antibody structure


2. Antibody Classes and Subclasses

By Dr. Mike Clark – University of Cambridge, UK

An excerpt from Antibody structure and function: antibody structure


3. Antibody Valency and Function

By Dr. Mike Clark – University of Cambridge, UK

An excerpt from Antibody structure and function: antibody function


4. The Role and Structure of Antibody Receptors (FcRs)

By Prof. Mark Cragg – University of Southampton, UK

An excerpt from The immunobiology of Fc receptors


5. An Introduction to Antibody Engineering

By Dr. Ian Wilkinson – Absolute Antibody, UK

An excerpt from Antibody engineering: beginnings to bispecifics and beyond


6. The use of Antibodies for Cancer Treatment

By Prof. Mark Cragg – University of Southampton, UK

An excerpt from Monoclonal antibodies in haemato-oncology


7. Monoclonal Antibodies for the Treatment of Type-1 Diabetes

By Dr. Robert Hilbrands – Brussels Free University, Belgium

An excerpt from Antibodies to control or prevent type 1 diabetes


8. Antibodies for Transplant Tolerance

By Prof. Luis Graca – University of Lisbon, Portugal

An excerpt from Tolerance induction to clotting factors with monoclonal antibodies


9. Autoantibodies and Autoimmune Diseases

By Dr. Luís Eduardo Coelho Andrade – UNIFESP, São Paulo, Brazil

An excerpt from Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes


10. Can Humanised Antibodies Reduce Immunogenicity?

By Dr. Geoffrey Hale – Chief Executive Officer of mAbsolve Ltd., UK

An excerpt from Therapeutic antibodies